Mass rollout planned across Southern Africa for new HIV drug
Administered just twice a year, the drug Lenacapavir offers near-complete protection — more than 99% — against HIV. After years of research and clinical trials, the preventive treatment has been approved and is now set to be rolled out on a large scale. Mass rollout campaigns are
Administered just twice a year, the drug Lenacapavir offers near-complete protection — more than 99% — against HIV. After years of research and clinical trials, the preventive treatment has been approved and is now set to be rolled out on a large scale. Mass rollout campaigns are planned across Southern Africa — South Africa, Zambia, Eswatini, Zimbabwe, Lesotho and Mozambique — the region hardest hit by HIV/AIDS. Our team on the ground reports.
This report comes from France 24. The story centres on Mass rollout planned across Southern Africa for new HIV drug. Full coverage and background context is available at the original source. Readers seeking more detail on this developing topic are encouraged to follow updates from France 24 and related outlets covering this beat.
